Effects of cinacalcet on bone mineral density in patients with secondary hyperparathyroidism

Nephrology Dialysis Transplantation

Volumn 20, Issue , 2005, Pages 1232-1237

  Lien, Yeong Hau H ^a,b   Silva, Arnold L ^a   Whittman, David ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Bone mineral density; Calcium sensing receptor; Cinacalcet; Cortical bone; Secondary hyperparathyroidism; Trabecular bone

Indexed keywords

CINACALCET; PARATHYROID HORMONE; PLACEBO; VITAMIN D DERIVATIVE;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE MINERAL; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR; HEMODIALYSIS; HUMAN; HYPOCALCEMIA; LUMBAR SPINE; MALE; MULTICENTER STUDY; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SECONDARY HYPERPARATHYROIDISM;

ADULT; BONE DENSITY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; MALE; MIDDLE AGED; MULTICENTER STUDIES; NAPHTHALENES; PARATHYROID HORMONE; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS;

EID: 20844432907     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh829     Document Type: Article

References (20)

1. Nemeth EF, Steffey ME, Hammerland LG et al. Calcimimetics with potent and selective activity on the parathyroid calcium receptor. Proc Natl Acad Sci USA 1998; 95: 4040-4045
2. Brown EM, MacLeod RJ. Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev 2001; 81: 239-297
3. Goodman WG. Calcimimetic agents and secondary hyperparathyroidism: rationale for use and results from clinical trials. Pediatr Nephrol 2003; 18: 1206-1210
4. Shoback DM, Bilezikian JP, Turner SA et al. The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism. J Clin Endocrinol Metab 2003; 88: 5644-5649
5. Block GA, Martin KJ, de Francisco ALM et al. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 2004; 350: 1516-1525
6. Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK. Association of elevated serum PO4, Ca x PO4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001; 12: 2131-2138
7. Hruska KA, Teitelbaum SL. Mechanisms of disease - renal osteodystrophy. N Engl J Med 1995; 333: 166-174
8. Foldes AJ, Arnon E, Popovtzer MM. Reduced speed of sound in tibial bone of haemodialysed patients: association with serum PTH level. Nephrol Dial Transplant 1996; 11: 1318-1321
9. Hruska KA, Saab G, Chaudhary LR et al. Kidney-bone, bone-kidney, and cell-cell communications in renal osteodystrophy. Semin Nephrol 2004; 24: 25-38
10. Parfitt AM. Renal bone disease: a new conceptual framework for the interpretation of bone histomorphometry. Curr Opin Nephrol Hypertens 2003; 12: 387-403
11. Taal MW, Masud T, Green D, Cassidy MJD. Risk factors for reduced bone density in haemodialysis patients. Nephrol Dial Transplant 1999; 14: 1922-1928
12. Dennison E, Eastell R, Fall CHD et al. Determinants of bone loss in elderly men and women: a prospective population-based study. Osteoporosis Int 1999; 10: 384-391
13. Schober HC, Han ZH, Foldes AJ et al. Mineralized bone loss at different sites in dialysis patients: implications for prevention. J Am Soc Nephrol 1998; 9: 1225-1233
14. Christiansen P, Steiniche T, Vesterby A et al. Primary hyperparathyroidism - iliac crest trabecular bone volume, structure, remodeling, and balance evaluated by histomorphometric methods. Bone 1992; 13: 41-49.
15. Parfitt AM, Rao DS, Stanciu J et al. Irreversible bone loss in osteomalacia - comparison of radial photon-absorptiometry with iliac bone histomorphometry during treatment. J Clin Invest 1985; 76: 2403-2412
16. Wada M, Ishii H, Furuya Y et al. NPS R-568 halts or reverses osteitis fibrosa in uremic rats. Kidney Int 1998; 53: 448-453
17. Ishii H, Wada M, Furuya Y et al. Daily intermittent decreases in serum levels of parathyroid hormone have an anabolic-like action on the bones of uremic rats with low-turnover bone and osteomalacia. Bone 2000; 26: 175-182
18. Abdelhadi M, Nordenstrom J. Bone mineral recovery after parathyroidectomy in patients with primary and renal hyperparathyroidism. J Clin Endocrinol Metab 1998; 83: 3845-3851
19. Chattopadhyay N, Yano S, Tfelt-Hansen J et al. Mitogenic action of calcium-sensing receptor on rat calvarial osteoblasts. Endocrinology 2004; 145: 3451-3462
20. Dvorak MM, Siddiqua A, Ward DT et al. Physiological changes in extracellular calcium concentration directly control osteoblast function in the absence of calciotropic hormones. Proc Natl Acad Sci USA 2004; 101: 5140-5145